Erratum - Interferon Beta-1a versus Glatiramer Acetate: Changes of Innate Im-munity in a Group of Women with Multiple Sclerosis (vol 86, pg 334, 2023)

Abstract

Multiple sclerosis (MS) is a chronic inflammatory autoimmune demyelinating disease that secondarily leads to axonal loss and associated brain atrophy. Diseasemodifying drugs (DMDs) have previously been studied for their ability to affect specific immunity.

This study investigates the effect of interferon beta-1a (INF) and glatiramer acetate (GA) administration on changes in innate immunity cell populations.

Keywords

• Multiple sclerosis
• Innate immunity
• Interferon beta-1a
• Glatiramer acetate
• Monocytes